CN Patent

CN103917265B — 鼻药递送装置

Assigned to Inbell Pharmaceutical Co · Expires 2017-02-15 · 9y expired

What this patent protects

一种递送从推进剂和药物制剂衍生的羽流的化合物递送装置。所述药物制剂以粉末、悬浮液、分散液或液体形式存在于鼻内剂型中。被推进的鼻内剂型沉积在鼻腔的嗅觉区内。沉积在嗅觉区内的药物被递送给大脑，从而避开血脑障壁。将来自加压罐的氢氟烷烃推进剂引导到扩散器和含药室，在此使鼻内剂型气雾化。气雾化的鼻内剂型穿过喷嘴，从而将羽流递送到用户鼻腔的嗅觉区。

USPTO Abstract

一种递送从推进剂和药物制剂衍生的羽流的化合物递送装置。所述药物制剂以粉末、悬浮液、分散液或液体形式存在于鼻内剂型中。被推进的鼻内剂型沉积在鼻腔的嗅觉区内。沉积在嗅觉区内的药物被递送给大脑，从而避开血脑障壁。将来自加压罐的氢氟烷烃推进剂引导到扩散器和含药室，在此使鼻内剂型气雾化。气雾化的鼻内剂型穿过喷嘴，从而将羽流递送到用户鼻腔的嗅觉区。

Drugs covered by this patent

Patent Metadata

Patent number
CN103917265B
Jurisdiction
CN
Classification
—
Expires
2017-02-15
Drug substance claim
No
Drug product claim
No
Assignee
Inbell Pharmaceutical Co
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.